At a glance
- Originator Kyorin Pharmaceutical
- Class Anti-inflammatories; Antirheumatics; Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 09 Mar 1999 No-Development-Reported for Rheumatoid arthritis in Japan (Unknown route)
- 26 Jul 1996 New profile
- 26 Jul 1996 Preclinical development for Rheumatoid arthritis in Japan (Unknown route)